11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Title:
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Author:
Rinne, Juha O Brooks, David J Rossor, Martin N Fox, Nick C Bullock, Roger Klunk, William E Mathis, Chester A Blennow, Kaj Barakos, Jerome Okello, Aren A de LIano, Sofia Rodriguez Martinez Liu, Enchi Koller, Martin Gregg, Keith M Schenk, Dale Black, Ronald Grundman, Michael